6-2-2022Cross-posted from NIAID NewsroomStrategy May Offer Alternative to Daily AntiretroviralsIndividuals with HIV who began taking antiretroviral therapy (ART) in the…
3-23-2022Cross-posted from NIAID NewsroomPhase 1 Study Is Among First to Examine mRNA Technology for HIVThe National Institute of Allergy and Infectious Diseases (NIAID)…
2-15-2022Cross-posted from NIAID NewsroomWoman Has Remained Without Detectable HIV for 14 MonthsA woman with HIV who received a cord blood stem cell transplant to treat …
12-21-2021Cross-posted from NIAID NewsroomApproval Marks Pivotal Expansion of HIV Prevention Options in the United StatesYesterday the U.S. Food and Drug Administration a…
12-15-2021Cross-posted from the NIAID NewsroomNIAID Scientists Developed Vaccine PlatformAn experimental HIV vaccine based on mRNA—the same platform technology used in …
11-30-2021NIH-Funded Study Estimates Global Progress Toward UNAIDS GoalCross-posted from NIAID NewsroomAmong people with HIV worldwide who are receiving antiretroviral th…
4-9-2021Cross-posted from NIAID NewsroomThe COVID-19 pandemic is affecting people with or at risk for HIV both indirectly, by interfering with HIV treatment and prevent…
2-19-2021For social media: NIH-funded researchers and others report on US efforts to end the #HIV epidemic in @TheLancet, calling for #HealthDisparities to be addressed.…
1-26-2021#HIVPrevention NEWS from @NIAIDnews: Infusions of an anti-HIV #antibody prevented acquisition of #HIV strains sensitive to that antibody, but did not significan…
12-3-2020Cross-posted from NIAID NewsroomGrant Awards Set Stage for Next Seven Years of Science-Driven HIV Clinical ResearchThe National Institute of Allergy and Infec…
